Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1988 Dec:9:76-9.

Receptor-mediated leukaemogenesis: hypothesis revisited

Affiliations
Review

Receptor-mediated leukaemogenesis: hypothesis revisited

J C Neil et al. Br J Cancer Suppl. 1988 Dec.

Abstract

The discovery of the first example of retroviral transduction of an immunological effector molecule has led us to reconsider the possible importance of cell surface receptors of the immune system in leukaemia development. Antigen receptors on lymphoid cells not only bind external ligands but are crucial in the control of cellular proliferation. The concept of autocrine stimulation in oncogenesis is already well established and we see no reason to exclude the possibility of analogous mechanism operating through antigen receptors. At present, we are investigating the oncogenic function of the retrovirus (FeLV-T17) carrying a T-cell receptor gene (v-tcr). In addressing the general concept of oncogenesis by ligand/receptor interactions in the immune system we face the problem of the diversity and, for T-cell antigen receptors, the complex nature of receptor-ligand interaction. Nevertheless, the implications of the model encourage us to continue to search for new experimental tools and approaches to the question.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell. 1987 Apr 24;49(2):263-71 - PubMed
    1. Cell. 1987 Apr 10;49(1):143-51 - PubMed
    1. Nature. 1987 Mar 12-18;326(6109):190-4 - PubMed
    1. J Virol. 1987 Apr;61(4):1067-72 - PubMed
    1. Nature. 1987 Jan 8-14;325(7000):125-30 - PubMed

Substances

LinkOut - more resources